Dandan Sun
1266 Fujin Road
Changchun, 130021, China
Changchun, 130021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Biomimetic mesenchymal stem cell membrane-coated nanoparticle delivery of MKP5 inhibits hepatic fibrosis through the IRE/XBP1 pathway.
Journal: Journal of nanobiotechnology
Published: July 31, 2024
Delivery of nucleic acid drugs for tumor therapy: Opportunities and challenges.
Journal: Fundamental research
Published: July 02, 2023
Construction of GPC3-modified Lipopolymer SiRNA Delivery System.
Journal: Current pharmaceutical design
Published: April 23, 2023
Delivery of melarsoprol using folate-targeted PEGylated cyclodextrin-based nanoparticles for hepatocellular carcinoma.
Journal: International journal of pharmaceutics
Published: November 23, 2022
Lenalidomide promotes melarsoprol-activated cGAS-STING-mediated immunotherapy for hepatocellular carcinoma via attenuating TNF-α activity.
Journal: Fundamental research
Published: November 20, 2022
Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 01, 2022
Role of Hyaluronic Acids and Potential as Regenerative Biomaterials in Wound Healing.
Journal: ACS applied bio materials
Published: January 11, 2022
Bovine serum albumin-based biomimetic gene complexes with specificity facilitate rapid re-endothelialization for anti-restenosis.
Journal: Acta biomaterialia
Published: November 01, 2021
A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.
Journal: International journal of pharmaceutics
Published: March 10, 2021
A cyclodextrin-based nanoformulation achieves co-delivery of ginsenoside Rg3 and quercetin for chemo-immunotherapy in colorectal cancer.
Journal: Acta pharmaceutica Sinica. B
Published: March 07, 2021
Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma.
Journal: Molecular cancer
Published: October 20, 2020
Nanodelivery of immunogenic cell death-inducers for cancer immunotherapy.
Journal: Drug discovery today
Published: August 11, 2020
Last Updated: 09/26/2026